Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in IVVD — Invivyd, Inc.

CIK 1729829 LONDON, X0
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,895,247
-$598,106 QoQ
Shares Held
3,320,238
+23.6% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 124 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. IVVD ranks #92 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 798,715 $240,437,176
2 INSM
INSMED Inc
 1,682,334 $179,370,451
3 REGN
Regeneron Pharmaceuticals, Inc.
 221,607 $138,180,828
4 ROIV
Roivant Sciences Ltd.
 3,454,496 $122,254,613
5 AXSM
Axsome Therapeutics, Inc.
 426,336 $104,354,262
6 APGE
Apogee Therapeutics, Inc.
 659,678 $87,559,060
7 TVTX
Travere Therapeutics, Inc.
 1,443,230 $81,989,896
8 RPRX
Royalty Pharma plc
 1,412,112 $79,177,119

All Filings in IVVD

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,895,247 3,320,238
2026-03-31 $3,493,353 2,687,195
2025-12-31 $520,300 210,648
2024-12-31 $14,072 31,767
2024-09-30 $170,184 166,848
2024-06-30 $248,595 225,996
2024-03-31 $1,387,184 312,429
2023-12-31 $479,915 121,806
2023-09-30 $30,258 17,799
2023-06-30 $79,306 75,530